Clinical Trial Update: A Study of Tralokinumab When Delivered Subcutaneously at Different Flow Rates to Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating subcutaneous delivery of tralokinumab at different flow rates in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tralokinumab (tralokinumab)

Snippet

Sponsor: MedImmune LLC | Conditions: Asthma, Healthy Subjects or Volunteers | Phase 1 | Status: COMPLETED | Results posted: 2018-11-23